Doctor'S Best Menopause Spectrum With Estrog-100, Non-Gmo, Vegan, Gluten Free, Soy Free, Veggie Caps, 30 Count

Estrog-100 Is Clinically Proven To Provide Relief From Hot Flashes, Help Manage Mood & Energy Swings, Help Alleviate Night Sweats And Promote Restful Sleep, And Improve Vaginal Dryness Clinical Studies Show That Estrog-100 Has No Estrogenic Effect And, Unlike Hormone Replacement Therapy, It Does Not Affect Weight Or Body Mass Index Gluten Free, Non-Gmo, Veggie Capsule During The Summer Months Products May Arrive Warm But Amazon Stores And Ships Products In Accordance With Manufacturers' Recommendations, When Provided About Two-Thirds Of Women Develop Uncomfortable Feelings Prior To, During, Or After Menopause. Sleep Disruptions, Nervous Tension, Sadness, Occasional Fatigue, And (Hot Flashes/Cold Sweats) Are All Commonly Reported By Women. Estrog-100 May Help Cope With Such Menopause-Related Discomforts. Estrog-100 Was Tested On Pre, Peri, And Post- Menopausal American Women In A Randomized, Double Blind, Placebo-Controlled Trial. The 64 Participants Took Either 514 Mg Of Estrog-100 Or A Placebo Tablet Every Day For 12 Weeks. To Be Eligible For The Study, Women Had To Have Moderate Or Severe Menopausal Discomforts As Identified By The Superman Menopausal Index (Kmi), A Questionnaire That Measures Changes In Uncomfortable Feelings Associated With Menopause. Potential Benefits Were Assessed By Kmi Questionnaires At 6 Weeks And At 12 Weeks. The Kmi Evaluates A Number Of Menopausal Parameters, Including Hot Flashes/Cold Sweats, Paresthesia (Numbness And Tingling), Sleep Interferences, Nervousness, Melancholia (Sadness Or Gloom), Vertigo (Dizzy Spells), Occasional Fatigue/Weakness, Palpitation (Pounding Of The Heart), Formication (Sensation Of Crawling Of The Skin) And Muscle Or Joint Discomforts. A Separate Questionnaire Assessed Changes In Vaginal Dryness. By The End Of The Study, The Average Kmi Score Was Significantly Lower In The Estrog-100 Group, Compared To The Placebo Group. Vaginal Dryness Was Also Significantly Improved In The Estrog-100 Group. The Individual Kmi Scores That Improved (Compared To The Control Group) Were Hot Flashes/Cold Sweats, Paresthesia, Sleep Interferences, Nervousness, Melancholia, Vertigo, Occasional Fatigue/Weakness And Muscle Or Joint Discomfort. The Estrog-100 Group Had No Major Adverse Effects. Importantly, This Group Showed No Increase In Estrogen Or Follicle Stimulating Hormone Levels